lemma health

Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.

Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.

Halobetasol propionate 0.05% ointment was significantly more effective than vehicle (placebo) in treating eczema. After 2 weeks of treatment, 83% of patients using halobetasol showed complete or marked improvement compared to 28% using vehicle. The medication was well-tolerated with no skin thinning reported.

Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The cream improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.

Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.

Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The medication improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.

Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.

Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.

Desonide hydrogel 0.05%, a low-potency steroid, was found to be safe and effective in treating children aged 6 months to 6 years with moderate-to-severe atopic dermatitis. The treatment showed good results in improving symptoms while having minimal impact on the body's hormone system.

Both desonide 0.05% ointment and hydrocortisone 2.5% ointment were found to be safe for children with atopic dermatitis when used for 4 weeks. Neither medication affected the body's natural cortisol production system.

Both desonide cream 0.1% and betamethasone cream were equally effective in treating childhood atopic dermatitis. However, desonide had less impact on the body's cortisol levels, making it potentially safer for children.

Desonide hydrogel 0.05% was found to be safe and effective in treating mild to moderate atopic dermatitis in children aged 3 months to 18 years. The treatment was well-tolerated and showed significant improvements compared to the vehicle (gel without medication).

Clobetasol propionate cream 0.05% was tested against a vehicle (cream without active ingredient) in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.

Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).

Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).

Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.

Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.

Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.

Clobetasol propionate (a very strong steroid) was more effective than flupredniden acetate (a medium-strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.

Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).

Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.

Both betamethasone and tacrolimus treatments effectively reduced eczema severity and inflammation. Betamethasone was better at reducing inflammation, while tacrolimus was better at improving skin hydration.

Both betamethasone and pimecrolimus improved skin barrier function and reduced symptoms in atopic dermatitis. While betamethasone was better at reducing symptoms, it caused skin thinning, making pimecrolimus potentially better for long-term use.

Betamethasone was more effective at reducing inflammation compared to pimecrolimus in atopic dermatitis skin samples. However, betamethasone may impair skin barrier repair, while pimecrolimus helps maintain it, suggesting pimecrolimus might be better for long-term treatment.

In people with controlled atopic dermatitis, betamethasone cream damaged the skin barrier after 4 weeks of use, while tacrolimus ointment improved skin barrier function. Tacrolimus was better at maintaining skin hydration and natural moisturizing factors.

A new cream containing fusidic acid and betamethasone (Fucicort Lipid cream) was found to be as effective as the existing cream formulation in treating infected atopic dermatitis. Both creams reduced severity scores by about 83% and cleared bacterial infection in about 90% of patients after 2 weeks of treatment.

Both tacrolimus and betamethasone improved skin barrier function during treatment. However, after stopping treatment, the benefits lasted longer with tacrolimus while the improvement from betamethasone partially wore off.

In people with controlled atopic dermatitis, betamethasone cream damaged the skin barrier after 4 weeks of use, while tacrolimus ointment improved skin barrier function. Tacrolimus was better at maintaining skin hydration and natural moisturizing factors.

Both betamethasone and pimecrolimus improved skin barrier function and reduced symptoms in atopic dermatitis. While betamethasone was better at reducing symptoms, it caused skin thinning, making pimecrolimus potentially better for long-term use.

Using mometasone cream together with an Alginate Skin Repair Mask was more effective than using mometasone cream alone for treating atopic dermatitis. The combination treatment showed better results with 97.5% effectiveness compared to 80% for cream alone, and had fewer side effects and disease recurrences.

In children with mild to moderate eczema, neither mometasone furoate 0.1% nor tacrolimus 0.1% affected their short-term growth rates. This suggests these treatments are safe to use in children without concerns about growth suppression.

Long-term intermittent treatment with mometasone furoate cream was effective for chronic hand eczema. Using the cream 3 times per week was more effective than using it 2 times per week or stopping treatment, with 83% of patients having no recurrence when using it 3 times weekly.

Using mometasone cream together with an Alginate Skin Repair Mask was more effective than using mometasone cream alone for treating atopic dermatitis. The combination treatment showed better results with 97.5% effectiveness compared to 80% for cream alone, and had fewer side effects and disease recurrences.

Both mometasone and fluticasone ointments were effective in treating moderate to severe atopic dermatitis in children. Using wet wrap dressings after 2 weeks of treatment provided additional improvement in symptoms.

A cream containing triamcinolone acetonide combined with laurocapram was more effective at treating atopic dermatitis compared to triamcinolone acetonide alone or vehicle control. The combination improved redness, skin thickness, and itching with minimal side effects.

Adding tetracycline to triamcinolone acetonide (a steroid) cream did not improve eczema symptoms more than using triamcinolone acetonide alone. However, the combination did reduce bacterial skin infection better than the steroid alone.

Both cream and ointment forms of triamcinolone acetonide were equally effective when used with wet wraps for treating atopic dermatitis in children. While patients found the ointment more difficult to apply, they preferred it for future treatments.

A cream containing triamcinolone acetonide combined with laurocapram was more effective at treating atopic dermatitis compared to triamcinolone acetonide alone or vehicle control. The combination improved redness, skin thickness, and itching with minimal side effects.

A low-dose steroid cream (triamcinolone acetonide) at 25 microg/g concentration was effective in treating mild to moderate atopic dermatitis. The low-dose steroid showed significant improvement compared to the cream without steroid after just one week of treatment.

A spray form of the steroid desoximetasone was tested in adults with atopic dermatitis. The spray significantly reduced itch and improved symptoms within 1 week, and these improvements lasted throughout the 4-week study. No side effects were reported.

Using a strong steroid cream (fluticasone) worked better than a mild steroid cream (hydrocortisone) for treating moderate eczema flare-ups in children. Children using the stronger steroid had better symptom improvement and quality of life over 24 weeks.

The study compared two ways of applying steroid cream in children with eczema - either on wet skin after a bath (soak and smear) or on dry skin. Both methods worked equally well, improving eczema by about 80-85%.

Using a strong steroid cream (fluticasone) worked better than a mild steroid cream (hydrocortisone) for treating moderate eczema flare-ups in children. Children using the stronger steroid had better symptom improvement and quality of life over 24 weeks.

The study compared two ways of applying steroid cream in children with eczema - either on wet skin after a bath (soak and smear) or on dry skin. Both methods worked equally well, improving eczema by about 80-85%.

A 3-day treatment with fluocinonide cream showed high patient adherence (100%) and significant improvement in eczema symptoms. By day 14, patients experienced 79% reduction in itching and 76% improvement in eczema severity, with more than half of patients achieving clear or almost clear skin.

A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.

Fluocinonide cream 0.1% was found to be safe and effective when used once daily in children with moderate to severe atopic dermatitis. Over 90% of patients showed improvement in their condition, and applying it once daily was as effective as twice daily with lower risk of side effects.

A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.

A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.

Ciclosporin was found to be more effective than prednisolone for treating severe eczema in adults. Only 1 out of 21 patients on prednisolone achieved stable improvement compared to 6 out of 17 patients on ciclosporin. The study was stopped early due to many patients on prednisolone experiencing significant worsening of their eczema.

Using methylprednisolone aceponate cream twice weekly along with moisturizer was more effective at preventing eczema flares than using moisturizer alone. After 16 weeks, 87.1% of patients using the steroid cream remained free from flares compared to 65.8% using just moisturizer.

In a study of experimental eczema caused by nickel allergy, methylprednisolone aceponate (a topical corticosteroid) provided fast itch relief. On average, significant itch relief was achieved within 1 day of treatment.

Both methylprednisolone aceponate 0.1% ointment and tacrolimus 0.03% ointment were effective in treating severe atopic dermatitis in children and adolescents. Methylprednisolone showed better results for reducing itch and improving sleep, and was more cost-effective.